Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 16,140
+240 (1.51%)
At close: Aug 11, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 110.46 billion as of August 12, 2026. Its market cap has increased by 22.83% in one year.
Market Cap
110.46B
Enterprise Value
16.15B
Revenue
56.49B
Ranking
n/a
PE Ratio
8.24
Stock Price
16,140.00
ChartMarket Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 110.46B, an increase of 690.81%. That is a compound annual growth rate of 9.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 110.46B | 23.11% |
| Dec 30, 2025 | 89.72B | -8.13% |
| Dec 30, 2024 | 97.66B | 27.18% |
| Dec 28, 2023 | 76.79B | -11.65% |
| Dec 29, 2022 | 86.92B | -34.80% |
| Dec 30, 2021 | 133.30B | -19.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio Solution | 159.99B |
| Prestige Biologics | 154.88B |
| TiumBio | 151.09B |
| ISU Abxis | 145.97B |
| Ensol Biosciences | 141.15B |
| ViGenCell | 124.43B |
| CORESTEMCHEMON | 101.81B |
| Choong Ang Vaccine Laboratory | 86.64B |